Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection

Cited by papers we hold 12

• Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells? · 2021
  No notice
• Type I and III interferon responses in SARS-CoV-2 infection · 2021
  No notice
• Innate immune sensing of coronavirus and viral evasion strategies · 2021
  No notice
• B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients · 2020
  No notice
• Activation and evasion of type I interferon responses by SARS-CoV-2 · 2020
  No notice
• Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines · 2020
  No notice
• Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies · 2020
  No notice
• Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation · 2020
  No notice
• COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment · 2020
  No notice
• A candidate multi-epitope vaccine against SARS-CoV-2 · 2020
  No notice
• Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development · 2019
  No notice
• Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.